Lung cancer biomarker campaign, launched with AstraZeneca, boosts its reach and adds pharma supporters

The groups are called the MET Crusaders, the EGFR Resistors, the KRAS Kickers and the ROS1ders — and members are non small cell lung cancer patients who share the same biomarkers. The groups, though, are also avid cancer biomarker testing advocates and supporters of LUNGevity’s “No One Missed” campaign to…
Click here to view original post